Catalyst Wire Dossier Catalyst Wire Dossier

OMS-302

· Omeros Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OMS-302, covering 2014-08-28 to 2014-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR) [Phase 2]

See pricing